Executive pay
Immunovant (IMVT) executive compensation
What Immunovant, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.
- 2026 proxy statement
Eric Venker, M.D., Pharm.D. paid $20.2M, pay ratio 67:1.
Filed Jul 22, 2026 - 2025 proxy statement
Peter Salzmann, M.D. paid $10.7M (+25% on the year), pay ratio 29:1.
Filed Jul 09, 2025